Literature DB >> 2431898

Highly selective agonists for substance P receptor subtypes.

U Wormser, R Laufer, Y Hart, M Chorev, C Gilon, Z Selinger.   

Abstract

The existence of a third tachykinin receptor (SP-N) in the mammalian nervous system was demonstrated by development of highly selective agonists. Systematic N-methylation of individual peptide bonds in the C-terminal hexapeptide of substance P gave rise to agonists which specifically act on different receptor subtypes. The most selective analog of this series, succinyl-[Asp6,Me-Phe8]SP6-11, elicits half-maximal contraction of the guinea pig ileum through the neuronal SP-N receptor at a concentration of 0.5 nM. At least 60,000-fold higher concentrations of this peptide are required to stimulate the other two tachykinin receptors (SP-P and SP-E). The action of selective SP-N agonists in the guinea pig ileum is antagonized by opioid peptides, suggesting a functional counteraction between opiate and SP-N receptors. These results indicate that the tachykinin receptors are distinct entities which may mediate different physiological functions.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2431898      PMCID: PMC1167226          DOI: 10.1002/j.1460-2075.1986.tb04571.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  30 in total

1.  Persistent action of N-methylated analogs of substance P on rat parotid slices.

Authors:  R Laufer; M Chorev; C Gilon; Z Y Friedman; U Wormser; Z Selinger
Journal:  FEBS Lett       Date:  1981-01-26       Impact factor: 4.124

2.  Synthesis and biological properties of enzyme-resistant analogues of substance P.

Authors:  B E Sandberg; C M Lee; M R Hanley; L L Iversen
Journal:  Eur J Biochem       Date:  1981-02

3.  A potent cyclic hexapeptide analogue of somatostatin.

Authors:  D F Veber; R M Freidlinger; D S Perlow; W J Paleveda; F W Holly; R G Strachan; R F Nutt; B H Arison; C Homnick; W C Randall; M S Glitzer; R Saperstein; R Hirschmann
Journal:  Nature       Date:  1981-07-02       Impact factor: 49.962

4.  Conformational energy studies on N-methylated analogs of thyrotropin releasing hormone, enkephalin, and luteinizing hormone-releasing hormone.

Authors:  P Manavalan; F A Momany
Journal:  Biopolymers       Date:  1980-11       Impact factor: 2.505

5.  Neuromedin K: a novel mammalian tachykinin identified in porcine spinal cord.

Authors:  K Kangawa; N Minamino; A Fukuda; H Matsuo
Journal:  Biochem Biophys Res Commun       Date:  1983-07-29       Impact factor: 3.575

6.  Synthesis and pharmacological characterization in vitro of cyclic enkephalin analogues: effect of conformational constraints on opiate receptor selectivity.

Authors:  J DiMaio; T M Nguyen; C Lemieux; P W Schiller
Journal:  J Med Chem       Date:  1982-12       Impact factor: 7.446

7.  The possible existence of multiple receptors for substance P.

Authors:  C M Lee; L L Iversen; M R Hanley; B E Sandberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-03       Impact factor: 3.000

8.  Tissue selectivity of substance P alkyl esters: suggesting multiple receptors.

Authors:  S P Watson; B E Sandberg; M R Hanley; L L Iversen
Journal:  Eur J Pharmacol       Date:  1983-01-28       Impact factor: 4.432

9.  The origin of acetylcholine released from guinea-pig intestine and longitudinal muscle strips.

Authors:  W D Paton; M A Zar
Journal:  J Physiol       Date:  1968-01       Impact factor: 5.182

10.  [pGlu6,Pro9]SP6-11, a selective agonist for the substance P P-receptor subtype.

Authors:  R Laufer; C Gilon; M Chorev; Z Selinger
Journal:  J Med Chem       Date:  1986-07       Impact factor: 7.446

View more
  55 in total

1.  Differences in neurokinin receptor pharmacology between rat and guinea-pig superior cervical ganglia.

Authors:  G R Seabrook; M Main; B Bowery; N Wood; R G Hill
Journal:  Br J Pharmacol       Date:  1992-04       Impact factor: 8.739

2.  CP-96,345, a non-peptide antagonist of substance P: I. Effects on the actions mediated by substance P and related tachykinins on the guinea-pig ileum and rabbit jejunum.

Authors:  F J Legat; T Griesbacher; F Lembeck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-09       Impact factor: 3.000

3.  The ventral tegmental area as a putative target for tachykinins in cardiovascular regulation.

Authors:  Kathleen Deschamps; Réjean Couture
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

4.  Regional variations in neurokinin receptor subtype contributions to muscularis mucosae and epithelial function in rat colon.

Authors:  Caroline B Appleyard; Marangelie Morales; William H Percy
Journal:  Dig Dis Sci       Date:  2006-03       Impact factor: 3.199

5.  Pharmacological properties of a potent and selective nonpeptide substance P antagonist.

Authors:  C Garret; A Carruette; V Fardin; S Moussaoui; J F Peyronel; J C Blanchard; P M Laduron
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

6.  Inhibition of tachykinin-induced hypotension in dogs by CP-96,345, a selective blocker of NK-1 receptors.

Authors:  J W Constantine; W S Lebel; H A Woody
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-10       Impact factor: 3.000

7.  Mu and kappa opioid receptor modulation of 5-HT3 and NK-3 receptor-evoked release of acetylcholine from the guinea-pig ileum myenteric plexus.

Authors:  A J Fox; I K Morton
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-07       Impact factor: 3.000

8.  Effect of SR 142801 on nitric oxide-dependent and independent responses to tachykinin NK3 receptor agonists in isolated guinea-pig colon.

Authors:  S Giuliani; C A Maggi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-11       Impact factor: 3.000

9.  Tachykininergic synaptic transmission in the coeliac ganglion of the guinea-pig.

Authors:  F Y Zhao; K Saito; K Yoshioka; J Z Guo; T Murakoshi; S Konishi; M Otsuka
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

10.  Proceedings of the British Pharmacological Society. University of Manchester, 13-15 September 1989.

Authors: 
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.